Acasti Pharma 뉴스 - ACST

기업명	주식 심볼	시장	주식 타입
Acasti Pharma Inc	ACST	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.0701	2.52%	2.8501	07:13:32

개장가	저가	고가	종가	전일 종가
2.77	2.70	2.93	2.8501	2.78

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
12/02/2024	22:00	EDGAR2	Form 8-K - Current report
12/02/2024	21:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/01/2024	22:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
08/01/2024	21:30	EDGAR2	Form 8-K - Current report
21/12/2023	06:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
21/12/2023	06:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
21/12/2023	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
15/12/2023	21:30	EDGAR2	Form 8-K - Current report
13/11/2023	21:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/10/2023	05:30	EDGAR2	Form 8-K - Current report
17/10/2023	05:31	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
12/10/2023	05:30	EDGAR2	Form 8-K - Current report
07/10/2023	05:30	EDGAR2	Form S-3 - Registration statement under Securities Act of..
28/09/2023	08:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
26/09/2023	21:10	EDGAR2	Form 8-K - Current report
06/09/2023	04:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
26/08/2023	06:01	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
26/08/2023	05:21	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
26/08/2023	05:15	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/08/2023	20:31	EDGAR2	Form 8-K - Current report
11/08/2023	20:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/07/2023	06:30	EDGAR2	Form 8-K - Current report
19/07/2023	05:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/07/2023	05:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/07/2023	05:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/07/2023	05:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/07/2023	05:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/07/2023	05:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/07/2023	05:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/07/2023	22:00	PRNUS	Acasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON..
07/07/2023	21:30	EDGAR2	Form 8-K - Current report
07/07/2023	21:00	PRNUS	Acasti Pharma Announces 1-for-6 Reverse Stock Split
06/07/2023	05:00	EDGAR2	Form 8-K - Current report
05/07/2023	22:00	PRNUS	Acasti Announces Alignment with FDA on GTX-104 Pivotal Phase..
23/06/2023	20:00	PRNUS	Acasti Pharma Reports Fiscal Year 2023 Operational Results
22/06/2023	22:00	PRNUS	Acasti Announces Appointment of New Scientific Advisory..
17/05/2023	22:00	PRNUS	Acasti to Participate in the Lytham Partners Spring 2023..
08/05/2023	20:00	PRNUS	Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

ACST Acasti Pharma Inc

최근 뉴스

ACST 과거 데이터 - 1일

ACST 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Acasti Pharma Inc (ACST) 뉴스

ACST Acasti Pharma Inc

최근 뉴스

ACST 과거 데이터 - 1일

ACST 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기